EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia

Kristin Basche iD, Deling He, Rebecca Langhough, Erin Jonaitis, Lianlian Du, Davide Bruno, Rachael Wilson, Bruce Hermann, Sterling Johnson, Kimberly Mueller

Journal of Alzheimer’s Disease · 2026

DOI: 10.1177/13872877261446477 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Kristin Basche und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Geriatrics and Gerontology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, U…. Hauptthemen laut MEDLINE: Alzheimer Disease, Mental Recall, Cognitive Dysfunction, tau Proteins. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous work has shown that proper name recall from the Logical Memory (LM) task is sensitive to PET and cerebrospinal fluid biomarkers of Alzheimer's disease (AD) in older adult populations. These findings indicate potential utility in identifying preclinical AD.

Objective

The purpose of this study is to validate previous findings of the association of proper name recall and blood-based plasma pTau217.

Methods

Participants came from the Wisconsin Registry for Alzheimer's Prevention study. We fit linear mixed effects models of longitudinal LM and proper name recall as a function of most recent pTau217 values. Follow-up analyses added interaction terms to models for group differences in sex and APOE ε4 allele carriage. As an exploratory aim, logistic regression models were used to examine if proper name recall aided in predicting clinical diagnosis.

Results

Participants with higher concentrations of pTau217 showed a steeper decline on both conventional LM and proper name recall. APOE ε4 allele carriers with higher concentrations of pTau217 showed a greater decline in longitudinal task performance, while there was no significant interaction for sex, indicating that men and women with high pTau217 show similar rates of decline.

Conclusions

Our findings validate that proper name recall is sensitive to blood-based pTau217. Measuring proper name recall may be an efficient marker assessing early cognitive change that could be leveraged when designing future cognitive tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMental RecallCognitive Dysfunctiontau ProteinsHumansMaleFemaleBiomarkersLongitudinal StudiesAgedNeuropsychological TestsApolipoprotein E4

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidearly diagnosislanguageplasma biomarkers

Substanzen

Biomarkerstau ProteinsApolipoprotein E4

Autor:innen und Institutionen

  • Department of Medicine, Division of Geriatrics and Gerontology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, WI, USA.
  • Wisconsin Alzheimer's Institute, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
  • Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
  • Department of Neurological Sciences, Rush Medical College, Chicago, IL, USA.

ORCID-Profile: Kristin Basche

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Basche, K., He, D., Langhough, R., Jonaitis, E., Du, L., Bruno, D., Wilson, R., Hermann, B., Johnson, S., & Mueller, K. (2026). Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261446477

Vancouver

Basche K, He D, Langhough R, Jonaitis E, Du L, Bruno D, et al. Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261446477

BibTeX
@article{Basche2026,
  author = {Basche, Kristin and He, Deling and Langhough, Rebecca and Jonaitis, Erin and Du, Lianlian and Bruno, Davide and Wilson, Rachael and Hermann, Bruce and Johnson, Sterling and Mueller, Kimberly},
  title = {Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261446477}
}
Kostenlos starten →